Related Experiment Videos
The active site of human C4a anaphylatoxin
Molecular Immunology
|June 1, 1983
Summary
The human complement C4a peptide shows biological activity, sharing receptors with C3a anaphylatoxin. Modifications in its C-terminal sequence significantly enhance C4a
Area of Science:
- Immunology
- Biochemistry
Background:
- Human complement C4a peptide is biologically active and shares receptors with C3a anaphylatoxin.
- Both C3a and C4a induce smooth muscle contraction and cross-desensitization.
Purpose of the Study:
- To investigate the anaphylatoxic activities of synthetic C4a peptides.
- To identify the active site of C4a and compare its activity to C3a.
Main Methods:
- Synthesis of C4a pentapeptide, octapeptide, and analogs.
- Assay of peptide activity on isolated guinea-pig ileal strips.
- Assessment of wheal and flare reactions in skin.
Main Results:
- The C4a pentapeptide showed significantly lower activity than the C3a pentapeptide.
- Specific amino acid substitutions in the C4a pentapeptide enhanced its activity.
- The C4a octapeptide and its analogs demonstrated increased biological activity.
- Synthetic C4a peptides blocked C3a and C4a actions on smooth muscle.
Conclusions:
- The active site of C4a, similar to C3a, resides at its C-terminus.
- C4a may contribute to the kinin-like activity observed in hereditary angioneurotic edema (HANE).
- Reappraisal of the sole derivation of HANE edema from C2 or kininogens is suggested.